1. Chen X, Zhang R, Zhang Q, et al. Microtia patients: Auricular chondrocyteECM is promoted by CGF through IGF-1 activation of the IGF-1R/PI3K/AKT pathway. J Cell Physiol. 2019;234(12):21817-21824. doi:10.1002/jcp.27316
2. Chen X, Zhang R. Microtia epigenetics. Medicine (Baltimore).2019;98(41):e17468.
3. Park C, Rosenblat JD, Brietzke E, et al. Stress, epigenetics and depression:asystematic review. Neurosci Biobehav Rev. 2019;102:139-152.
4. Bajrami E, Spiroski M. Genomic imprinting. Open Access Maced J MedSci 2016;4(1):181-184.
5. Tenhunen J Salminen M, Lundström K, et al. Genomic organization ofthe human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem. 1994;223(3):1049-1059.
6. Mill J, Dempster E, Caspi A, et al. Evidence for monozygotic twin (MZ)discordance in methylation level at two CpG sites in the promoter regionof the catechol-O-methyltransferase (COMT) gene. Am J Med Genet BNeuropsychiatr Genet. 2006;141B(4):421-425.
7. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell.2012;149(6):1192-1205.
8. Iqbal K, Dhakal P, Pierce SH, et al. Catechol-O-methyltransferase andPregnancy Outcome:an Appraisal in Rat. Reprod Sci. 2021;28(2):462-469.
9. Mohamed NE, Hay T, Reed KR, et al. APC2 is critical for ovarian WNTsignalling control, fertility and tumour suppression. BMC Cancer.2019;19(1):677.
10. Bhat RV, Baraban JM, Johnson RC, et al. High levels of expression ofthe tumor suppressor gene APC during development of the rat centralnervous system. J Neurosci. 1994;14(5 Pt 2):3059-3071.
11. Ishikawa TO, Tamai Y, Li Q, et al. Requirement for tumor suppressor Apcin the morphogenesis of anterior and ventral mouse embryo. Dev Biol.2003;253(2):230-246.
12. McEwen BS. Physiology and neurobiology of stress and adaptation:centralrole of the brain. Physiol Rev. 2007;87(3):873-904.
13. Korgun ET, Ozmen A, Unek G, et al. The effects of glucocorticoids onfetal and placental development. X Qian (Ed.),Glucocorticoids - NewRecognition of Our Familiar Friend, InTech, Croatia 2012;305-336.
14. Schmidt M, Lax E, Zhou R, et al. Fetal glucocorticoid receptor (Nr3c1)deficiency alters the landscape of DNA methylation of murine placentain a sex-dependent manner and is associated to anxiety-like behavior inadulthood. Transl Psychiatry.2019;9(1):23.
15. Palma-Gudiel H, Córdova-Palomera A, Leza JC, et al. Glucocorticoidreceptor gene (NR3C1) methylation processes as mediators of earlyadversity in stress-related disorders causality:A critical review.Neuroscience & Biobehavioral Reviews. 2015;55:520-535.
16. Money KM, Stanwood GD. Developmental origins of brain disorders:rolesfor dopamine. Front Cell Neurosci. 2013;7:260.
17. Yu Q, Liu YZ, Zhu YB, et al. Genetic labeling reveals temporal and spatialexpression pattern of D2 dopamine receptor in rat forebrain. Brain StructFunct. 2019;224(3):1035-1049.
18. Lovic V, Belay H, Walker CD,et al. Early postnatal experience and DRD2genotype affect dopamine receptor expression in the rat ventral striatum.Behav Brain Res. 2013;237:278-282.
19. Grandy DK, Litt M, Allen L, et al. The human dopamine D2 receptor geneis located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am JHum Genet 1989;45(5):778-785.
20. Aytac HM, Oyaci Y, Pehlivan M, et al. DNA Methylation Pattern ofGene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish PatientsDiagnosed with Schizophrenia. Clin Psychopharmacol Neurosci.2022;20(4):685-693.
21. Nohesara S, Ghadirivasfi M, Barati M, et al. Methamphetamine-InducedPsychosis Is Associated With DNA Hypomethylation and IncreasedExpression of AKT1 and Key Dopaminergic Genes. Am J Med Genet BNeuropsychiatr Genet. 2016;171(8):1180-1189.
22. Nohesara S, Ghadirivasfi M, Mostafavi S, et al. DNA hypomethylation ofMB-COMT promoter in the DNA derived from saliva in schizophreniaand bipolar disorder. J Psychiatr Res. 2011;45(11):1432-1438. doi:10.1016/j.jpsychires.2011.06.013
23. Lind GE, Kleivi K, Meling GI, et al. ADAMTS1, CRABP1, and NR3C1identified as epigenetically deregulated genes in colorectal tumorigenesis.Cell Oncol. 2006;28(5-6):259-272. doi:10.1155/2006/949506
24. Xia Y, Hong Q, Chen X, et al. APC2 and CYP1B1 methylation changes inthe bone marrow of acute myeloid leukemia patients during chemotherapy.Experime Therapeut Med. 2016;12(5):3047-3052.
25. Carey JC, Park AH, Muntz HR. External Ear. In:Stevenson RE, editor.Human malformations and related anomalies. Oxford UniversityPress;Oxford;New York. 2006;329-338.
26. Luquetti DV, Heike CL, Hing AV, et al. Microtia: Epidemiology & Genetics.Am J Med Genet A. 2012;158A(1):124-139.
27. Chafai Elalaoui S, Cherkaoui Jaouad I, Rifai L, et al. Autosomal dominantmicrotia. Eur J Med Genet. 2010;53(2):100-103.
28. Artunduaga MA, Quintanilla-Dieck Mde L, Greenway S, et al. A ClassicTwin Study of External Ear Malformations, Including Microtia. N Engl JMed. 2009;361(12):1216-1218.
29. Okajima H, Takeichi Y, Umeda K, Baba S. Clinical analysis of 592 patientswith microtia. Acta Otolaryngol Suppl. 1996;525:18-24.
30. Smith ZD, Meissner A. DNA methylation:roles in mammaliandevelopment. Nat Rev Genet. 2013;14(3):204-220.
31. Trasler JM,Trasler DG, Bestor TH, et al. DNA methyltransferase in normaland Dnmtn/Dnmtn mouse embryos. Dev Dyn. 1996;206(3):239-247.
32. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping ofmethylated cytosines. Nucl Acids Res. 1994;22(15):2990-2997.
33. Breton-Larrivée M, Elder E, McGraw S. DNA methylation, environmentalexposures and early embryo development. Anim Reprod. 2019;16(3):465-474.
34. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy andbirth defects:a systematic review based on 173,687 malformed cases and11.7 million controls. Hum Reprod Update. 2011;17(5):589-604.
35. Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns andmaternal smoking in pregnancy:genome-wide consortium meta-analysis.Am J Hum Genet. 2016;98(4):680-696.
36. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations bydietary and other environmental factors. Adv Genet. 2010;71:3-39.
37. Ozaki Y, Yoshino Y, Yamazaki K, et al. DRD2 methylation to differentiatedementia with Lewy bodies from Parkinson’s disease. Acta Neurol Scand.2020 ;141(2):177-182.
38. Aytac HM, Oyaci Y, Pehlivan M, et al. DNA Methylation Pattern ofGene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish PatientsDiagnosed with Schizophrenia. Clin Psychopharmacol Neurosci. 2022;20(4):685-693.
39. Oyaci Y, Aytac HM, Pasin O,et al. Detection of altered methylation ofMB-COMT promotor and DRD2 gene in cannabinoid or syntheticcannabinoid use disorder regarding gene variants and clinical parameters.J Addict Dis. 2021;39(4):526-536.
40. Hill SY, Sharma VK. DRD2 methylation and regional grey matter volumesin young adult offspring from families at ultra-high risk for alcoholdependence. Psychiatry Res Neuroimaging. 2019;286:31-38